Investing in the Future of Our Health

The prevalence of chronic diseases is accelerating due to an ageing population, creating an economic burden on the global healthcare system. This is exacerbated by a diminishing workforce that would otherwise be able to finance the costs and a healthcare supply mismatch, as exemplified by the pandemic. Traditional barriers to change are shifting and the pandemic accelerated trends such as digital health and therapeutics. The increase in generation of data and development of computational biology tools approaches has resulted in a techbio wave, creating a paradigm shift in the way that next-generation drugs are discovered by platforms. We are excited by the convergence of multiple disciplines and how this will revolutionise healthcare from the delivery of services through to longevity.

Scroll to Top